Multivitamins before pregnancy may prevent prematurity

- Last updated on GMT

Related tags: Childbirth

Women who take multivitamins before becoming pregnant are less
likely to give birth to premature babies, suggests a new study.

It found that women who took multivitamins before conceiving were half as likely to deliver their babies before 37 weeks of pregnancy.

However, continuing the multivitamins through the first months of pregnancy appeared to have no influence on the risk of prematurity, write the researchers in the 1 November issue of the American Journal of Epidemiology​(160(9):886-92).

Previous research suggests that multivitamin use before and during pregnancy can diminish diet-related deficiencies of certain micronutrients and potentially prevent preterm birth, note the researchers from the University of North Carolina at Chapel Hill.

To assess this association, the authors analysed data from a large study that recruited 2,010 women at 24-29 weeks of pregnancy in four different prenatal care clinics between 1995 to 2000.

While vitamin use before conception reduced the risk of premature birth, prenatal and periconceptional use showed no impact on the likelihood of preterm birth.

The researchers noted that further studies are needed with a larger sample of preconceptional users to confirm their findings.

In the UK about 8 per cent of babies are born prematurely, before 37 rather than the usual 40 weeks of gestation.

Previous research has demonstrated that folic acid, found in multivitamins, helps to prevent birth defects.

Related news

Related products

show more

HRB are ideal probiotics for human health

HRB are ideal probiotics for human health

Morinaga Milk Industry Co., Ltd. | 20-Nov-2019 | Technical / White Paper

Evidence is accumulated that the physiological benefits of probiotics bifidobacteria are not only strain-specific but also dependent on their residential...

Vitamin K2 Success Stories: NattoPharma

Vitamin K2 Success Stories: NattoPharma

NattoPharma USA, Inc. | 23-Sep-2019 | Case Study

Partnership means companies are bound to the process – from formulation and testing to marketing and meeting demand. That is what companies selecting MenaQ7®...

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Related suppliers

Follow us

Featured Events

View more


View more